Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.65 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.35 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.35 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexanone SCHEMBL8679167 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL4903664 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2196651 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2197202 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL17629439 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2193717 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL9355151 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL1472595 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2197197 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL110906 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1944 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | claimed |
| EP-4516118-A2 | USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE | Symrise AG (DE) | 2025-03-05 | — | — | EP | claimed |
| CN-111051483-B | Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| EP-3665163-B1 | USE OF AMBROCENIDE® FOR ENHANCING THE FRAGRANCE OF LILLIES OF THE VALLEY | SYMRISE AG (DE) | 2024-12-25 | — | — | EP | claimed |
| US-20240173227-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | SYMRISE AG (DE) | 2024-05-30 | — | — | US | claimed |
| US-20240122834-A1 | MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION | SYMRISE AG (DE) | 2024-04-18 | — | — | US | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-6057372-A | CONSISTING OF MACROCYCLIC LACTONES OR MACROCYCLIC KETONES; BODY DEODORIZERS, SUPPRESSION OF PIMPLES | SODA AROMATIC CO., LTD. (JP) | 2000-05-02 | — | — | US | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0855180-A1 | ANTIBACTERIAL AGENTS AND COSMETICS AND CLOTHES CONTAINING THE SAME | SODA AROMATIC COMPANY, LIMITED (JP) | 1998-07-29 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240122834-A1 | MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION | MC1R, OR51E2, TYR | TRIM24 2056/4885TRIM33 2123/4885ALDH1A1 817/4885 |
| US-20240173227-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | IPO5, OR51E2, FDFT1 | TRIM24 647/4885TRIM33 2680/4885ALDH1A1 366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.